{"id":16099,"name":"BioRock Ventures","slug":"biorock-ventures","website":"https://biorockventures.com","hqGeo":null,"stageFocus":["Seed","Series A"],"sectorTags":["Healthcare"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Seed VC fund investing in startups developing best-in-class medicines and novel FDA-regulated therapeutic drugs. The firm explicitly backs private life science companies across angel, seed, Series A, and later stages.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Immusoft","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops engineered B cell therapies to produce therapeutic proteins in patients","amountUsd":null,"relevanceNote":null,"fundName":"Fund II"},{"companyName":"Vidya Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Exit, acquired","amountUsd":null,"relevanceNote":null,"fundName":"Fund II"},{"companyName":"AN2","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Primmune Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops immune-system-based therapies","amountUsd":null,"relevanceNote":null,"fundName":"Fund I"},{"companyName":"PTM Therapeutics, Inc.","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Therapeutics company","amountUsd":null,"relevanceNote":null,"fundName":"Fund I"},{"companyName":"Vaxcyte","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops broad-spectrum vaccines","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"AN2 Therapeutics","companyUrl":null,"stage":"not specified","sector":"biotech / small-molecule drug development","investmentYear":null,"description":"Develops small-molecule therapeutics from a boron chemistry platform","amountUsd":null,"relevanceNote":null,"fundName":"Fund I"}],"partnerCount":1,"partners":[{"id":52573,"name":"Mary Wheeler","title":"Managing Director","seniority":null,"focusTags":["therapeutics startups","M&A","licensing deals"],"linkedinUrl":"https://www.linkedin.com/in/marywheelermbaphd","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":"Mary is founding managing partner of BioRock Ventures in the Bay Area, CA. Mary began two decades of operating experience as a therapeutics startup founder in Boston. She moved to roles leading negotiations, business and technical evaluations for M&A and licensing deals as well as strategy roles at large and medium pharmaceuticals companies like Johnson & Johnson and Forest, now Allergan/Abbvie, in NYC. She also has served as consulting CBO for several dozen early stage ventures around the world. She began venture investing a decade ago where she helped form and put first money into two new companies which each had IPO exits valued over $1 Billion. Mary is a Kauffman Fellow, earned an MBA from MIT Sloan, a PhD from Princeton University and an undergraduate degree from Yale University.","recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[],"contentUpdatedAt":null,"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-27T01:31:05.641Z"}